Table of Contents Table of Contents
Previous Page  253 / 1082 Next Page
Information
Show Menu
Previous Page 253 / 1082 Next Page
Page Background

S240

ESTRO 36 2017

_______________________________________________________________________________________________

Three hollow plexiglass cubes filled with VIPAR polymer

gel were produced and used in this study. Planning CT

scans of each one of the gel filled cubes and arbitrary

RStructures have been used for treatment planning. Cube-

1 was planned to be irradiated with mono-energetic

proton beams (90MeV & 115MeV) avoiding overlapping of

the irradiated gel areas (Max Dose : ~ 15 Gy). Cube-2 was

planned to be irradiated with a multi-energetic beam

forming a spread-out Bragg peak (SOBP) (Max Dose : ~ 13

Gy). Cube-3 was planned to be irradiated with two

opposing beams (Max Dose : ~ 13 Gy) each delivering an

overlapping and uniform SOBP. Set-up and irradiation of

each cube followed. One day post-irradiation each cube

was MRI scanned in order to derive high spatial resolution

3D-T2 maps that were subsequently co-registered to the

corresponding planning-CT scans and DICOM-RT Dose and

Structure data. Assuming a linear gel dose response, 1D,

2D and 3D dose measurements were derived and compared

against corresponding TPS data.

Results

VIPAR gel response seem to be non-dependent on LET for

LET values < ~6 keV/µm implying that their use for most

clinical cases is acceptable. No matter their LET

dependence, the protons range can be well verified. Even

if uncertainties related to imaging, set-up, beam delivery,

dose calculations, co-registration, gels LET dependence

were incorporated, the range measured by the proposed

method was within ~ 1 mm to that calculated by TPS.

Moreover, the corresponding ranges at the 80% value of

the maximum dose point for both TPS and polymer gels

derived percentage depth dose profiles (pdds) were equal

within ~1 mm. Additionally, for the opposed beams

experiment (cube-3), the proposed methodology results in

even more accurate dosimetry due to the reduced LET

values inside the SOBP compared to the high LET values

present in the irradiated schemes of cubes 1 and 2.

Conclusion

The proposed End-to-End Quality Assurance method based

on polymer gel dosimetry, provides valuable outcomes for

proton range verification and 3D proton dosimetry.

A. T2-map of the irradiated polymer gel cubic phantom,

co-registered to the corresponding planning-CT scans and

TPS calculated dose.

B. Pdd measurements

C. Isodoses in an arbitrary 2D plane

D. GI (5%dose/ 2mm criteria) calculated by the data

presented in C

First row: SOBP irradiation. Second row: Mono-energetic

115 MeV irradiation

Poster Viewing : Session 10: RTT

PV-0456 Volumetric Modulated Arc Therapy for

patients with bilateral breast cancer

S. Lutjeboer

1

, J.W.A. Rook

1

, G. Stiekema

1

, A.P.G. Crijns

1

,

N.M. Sijtsema

1

, E. Blokzijl

1

, J. Hietkamp

1

, J.A.

Langendijk

1

, A.J. Borden van der

1

, J.H. Maduro

1

1

UMCG University Medical Center Groningen, Radiation

Oncology, Groningen, The Netherlands

Purpose or Objective

The objective was to study the differences in target

coverage and dose-volume parameters for heart and lung

between Deep Inspiration Breath Hold (DIBH) 3D

Conformal Radiation Therapy (3D-CRT), DIBH Volumetric

Modulated Arc Therapy (VMAT) and free breathing

Intensity Modulated Radiation Therapy (IMRT) in patients

treated with synchronous bilateral breast cancer.

Material and Methods

This planning comparative study was conducted in nine

patients previously treated for synchronous bilateral

breast cancer. These patients were treated with either

DIBH 3D-CRT or IMRT in free breathing. All patients were

treated with whole breast irradiation and those requiring

a boost were given a simultaneously integrated boost

(SIB). Three treatment plans were constructed for each

patient individually; a DIBH 3D-CRT plan, a DIBH VMAT

plan and an IMRT plan in free breathing. DIBH IMRT is

clinically not feasible due to the extended duration of

treatment. Three patients were treated without a boost,

three were treated with unilateral SIB and the remaining

patients were treated with double sided SIB. DIBH 3D-CRT

plans were created using tangential fields for both breasts

and up to three boost fields for each breast, if a boost was

required. IMRT plans were created using 14 fields around

the patient, 24° apart, covering both breasts and

simultaneously covering the boost target in one or both

breasts. DIBH VMAT plans without boost targets were

created using eight 30° arcs, four on each side, oriented

in a tangential design. Four 60° arcs, in a tangential

design, were used in patients with boost targets, two for

each breast, with an additional semi-circle arc on either

side covering the boost targets. The parameters reviewed

were V95% (percentage of volume receiving 95% of the

prescription dose) PTV1 and PTV2 coverage, with PTV1

being the elective target and PTV2 the boost target, the

mean heart dose and heart left ventricle V5 (percentage

of volume receiving 5 Gy), mean lung dose, lung V5 and

lung V20. The parameters were compared using the paired

T-test for normally distributed data and the Wilcoxon

signed rank-test for not normally distributed data. Three

statistical analyses were performed on each parameter,

therefore the Bonferroni correction was applied.

P

≤0.016

was considered statistically significant in this study.

Results

Target coverage of PTV1 and PTV2 were comparable

between the three techniques (table 1), except the V95%

PTV1 left. All dose volume parameters of the heart and

lung were lower for the DIBH VMAT technique (table1) in

comparison with the DIBH 3D-CRT and free breathing IMRT

technique.

Conclusion

DIBH VMAT is the most optimal radiation technique in the

treatment for patients with synchronous bilateral breast

cancer. Both PTV coverage and the sparing of the organs

at risk give better results for DIBH VMAT in comparison

with DIBH 3D-CRT and IMRT in free breathing.

PV-0457 Delay between planning and stereotactic

radiotherapy for brain metastases: margins still

accurate?

C. Bonnet

1

, A. Dr Huchet

1

, E. Blais

1

, J. Dr Benech-Faure

1

,

R. Dr Trouette

1

, V. Dr Vendrely

1

1

Hopital Haut Leveque, Radiotherapy, Pessac, France